Press release 2024-04-16
Galenica successfully places a bond of over CHF 100 million
Today, Galenica successfully placed a fixed rate bond of over CHF 100 million.
The bond has a term of 7 years and an annual coupon of 1.65%. The proceeds from the transaction will be used for general corporate purposes. With this new bond, Galenica is reducing its short-term financial liabilities and securing its long-term financing. The term until 2031 ideally complements the terms of the outstanding bonds from 2026 (CHF 180 million, coupon 1.0%) and 2029 (CHF 240 million, coupon 2.35%).
UBS and Zürcher Kantonalbank are joint lead manager for this issue. An application for admission to trading on the SIX Swiss Exchange for the bond is being made.
You might also be interested in this
More responsibility for pharmacies in providing care from 2027
The revision of the Health Insurance Act (HIA) strengthens the position of pharmacies as important players in the healthcare system. The development of the around 380 pharmacies in the Galenica network shows how investments in training, infrastructure and digital solutions are already paying off today.
The pharmacy is becoming the first point of contact for health issues
With long waiting times for GPs and overcrowded emergency departments, many people are looking for faster access to medical assistance. Pharmacies are playing an increasingly important role in this. Galenica shows how pharmacies can meaningfully relieve strain on our healthcare system.
